The designation will allow for expedited development of the pump system as the South Korean company prepares to submit it for FDA approval.

Several hundred participants take part in new effort to collect real-world data for type 1 diabetes research.

The proposed rule is an attempt to make sure Medicaid and Medicare recipients more directly benefit from drug discounts.

Glooko also recently announced a partnership to integrate with Novo Nordisk’s soon-to-be-released smart insulin pens.

The insulin maker also is asking European regulators for expanded Fiasp approval to treat the pediatric population.

A chef discusses his journey from low-carb skeptic to low-carb devotee and shares a favorite recipe.

The t:slim X2 is the first pump given the label of alternative controller-enabled (ACE) pump by the FDA.

The company plans to sell this insulin formulation for roughly half the list price of Humalog.

Dexcom announces an update to its app for its G6 continuous glucose monitor that brings five new features for the Apple iOS platform, including the ability to ask Siri for blood glucose readings.

Insulin was one of a handful of drugs that were mentioned often in the hearing. Here are five takeaways from the hearing.